Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?
Weller
Michael
M
Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, Zurich, Switzerland.
Wick
Wolfgang
W
Hegi
Monika E
ME
Stupp
Roger
R
Tabatabai
Ghazaleh
G